Bausch Health Companies Inc (BHC) Stock Price, Quote & AI Analysis

Live BHC stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Bausch Health Companies Inc.

TradeVae provides AI-driven analysis and real-time market intelligence for Bausch Health Companies Inc (BHC), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.

BHC
Bausch Health Companies Inc
real-time
$0.00 +0.00 (+0.00%)
Open
5.700000
High
5.845000
Low
5.640000
Volume
631,033
VWAP
-
Market Cap
$2,126,767,155.24
52W Range
$4.25 - $8.69
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Bausch Health Companies Inc's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Bausch Health Companies Inc Overview

Company information

Company Overview

Bausch Health Cos., Inc. engages in the development, manufacture and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: Salix, International, Solta Medical, Diversified Products, and Bausch + Lomb. The Salix segment consists of sales in the U.S. of GI products. Sales of the Xifaxan product line. The International segment comprises of sales, except for sales of Bausch + Lomb products and Solta aesthetic medical devices, outside the U.S and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical and OTC products. The Solta Medical segment refers to global sales of Solta Medical aesthetic medical devices. The Diversified Products segment covers sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, generic products, ortho dermatologic, and dentistry products. The Bausch + Lomb segment are global sales of Bausch + Lomb vision care, surgical and ophthalmic pharmaceuticals products. The company was founded on March 29, 1994, and is headquartered in Laval, Canada.

Company Details
Market Cap
$2.17B
Shares Outstanding
372,289,178
Weighted Shares Outstanding
370,516,926
CEO
Thomas J. Appio
Address
2150 ST. ELZEAR BLVD. WEST, QUEBEC, A8, H7L 4A8
Employees
20,700
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
XNYS

Technical Indicators

Key technical analysis metrics and signals

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Bausch Health Companies Inc Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...